HIV PREVENTION: FROM THE BENCH TO POPULATION

Tue, 2/15: 9:45 AM - 11:45 AM MST
Oral-07 
Oral Abstract Session 
Denver - Virtual Conference 
Room: Room 3 

Oral Abstract Moderator(s)

Dr Sharon L Hillier, University of Pittsburgh Medical Center
Dr Jean-Michel Molina, University of Paris

Clinical

(G) Clinical Pharmacology in Adults

Epidemiology/Public Health

(V) HIV Prevention Interventions in Adults
(Y) Implementation and Scale-Up of Prevention and Treatment for HIV and Impact of COVID-19 on HIV-Related Programs

Presentations

INTRODUCTION OF SPEAKERS PART I

Oral Abstract Moderator

Dr Sharon L Hillier, University of Pittsburgh Medical Center

LONG-ACTING INJECTABLE FOR PREVENTION OF HIV AND UNPLANNED PREGNANCY

View Abstract 80

Oral Abstract Presenter

Ms Isabella Young, University of North Carolina at Chapel Hill

PHASE I STUDY OF COMBINATION ANTI-HIV NEUTRALIZING ANTIBODIES IN HIV-NEGATIVE ADULTS

View Abstract 81

Oral Abstract Presenter

Dr Magdalena E Sobieszczyk, Columbia University

PHASE I PK, SAFETY, AND ACCEPTABILITY STUDY OF A 90-DAY TENOFOVIR VAGINAL RING

View Abstract 82

Oral Abstract Presenter

Dr Albert Liu, San Francisco Department of Public Health

ISLATRAVIR DISTRIBUTION IN MUCOSAL TISSUES, PBMC, & PLASMA AFTER MONTHLY ORAL DOSING

View Abstract 83

Oral Abstract Presenter

Dr Craig Walter Hendrix, Johns Hopkins University

LIVE QUESTIONS AND ANSWERS PART I

Oral Abstract Moderator

Dr Sharon L Hillier, University of Pittsburgh Medical Center

Oral Abstract Presenter(s)

Dr Craig Walter Hendrix, Johns Hopkins University
Dr Albert Liu, San Francisco Department of Public Health
Dr Magdalena E Sobieszczyk, Columbia University
Ms Isabella Young, University of North Carolina at Chapel Hill

INTRODUCTION OF SPEAKERS PART II

Oral Abstract Moderator

Dr Jean-Michel Molina, University of Paris

THE BIDIRECTIONAL EFFECTS OF HORMONE THERAPY AND PrEP IN TRANSGENDER INDIVIDUALS

View Abstract 84

Oral Abstract Presenter

Dr Jill Blumenthal, University of California San Diego

PHASE IIA TRIAL OF ISLATRAVIR QM FOR HIV PrEP: WEEK 24 METABOLIC AND RENAL OUTCOMES

View Abstract 85

Oral Abstract Presenter

Dr Pippa J Macdonald, Desmond Tutu HIV Centre

COUNTERFACTUAL ESTIMATION OF CAB-LA EFFICACY AGAINST PLACEBO USING EXTERNAL TRIALS

View Abstract 86

Oral Abstract Presenter

Dr Deborah Donnell, Fred Hutchinson Cancer Research Center

DIFFERENT HIV PROTECTION FOR TRADITIONAL AND MEDICAL CIRCUMCISION IN HPTN 071(PopART)

View Abstract 87

Oral Abstract Presenter

Ms Kidist Belay Zewdie, University of Washington

CHOICE AND ADHERENCE TO DAPIVIRINE RING OR ORAL PrEP BY YOUNG AFRICAN WOMEN IN REACH

View Abstract 88

Oral Abstract Presenter

Dr Kenneth Ngure, Jomo Kenyatta University of Agriculture and Technology

LIVE QUESTIONS AND ANSWERS PART II

Oral Abstract Moderator

Dr Jean-Michel Molina, University of Paris

Oral Abstract Presenter(s)

Dr Jill Blumenthal, University of California San Diego
Dr Deborah Donnell, Fred Hutchinson Cancer Research Center
Dr Pippa J Macdonald, Desmond Tutu HIV Centre
Dr Kenneth Ngure, Jomo Kenyatta University of Agriculture and Technology
Ms Kidist Belay Zewdie, University of Washington